On Wednesday, Inspire Medical System stock reached an important technical benchmark, seeing its Relative Strength (RS) Rating jump into the 90-plus percentile with an improvement to 91, up from 87 the day before.
When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength. This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the best-performing stocks typically have an 80 or better RS Rating as they launch their biggest runs.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Inspire Medical Systems Stock A Buy?
The IBD 50 stock is working on a second-stage consolidation with a 286.39 buy point. See if it can clear the breakout price in heavy trading. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The sleep apnea device maker's earnings growth increased last quarter from 0% to 67%. But revenue gains fell from 72% to 70%. The company is expected to report its latest numbers on or around May 4.
Inspire Medical Systems stock holds the No. 18 rank among its peers in the Medical-Products industry group. Lantheus, United Guardian and Edwards Lifesciences are among the top 5 highly rated stocks within the group.
